UVA Health System frequently opens new clinical trials, offering your patients the latest investigational treatments.
For a complete list of active cancer trials and study coordinator contact information, visit our newly launched Find a Clinical Trial website. If you have patients who may be eligible to participate in a cancer clinical trial, please email cancerclinicaltrials@virginia.edu.
Lymphoma (IRB-HSR #19675)
A Randomized Double-Blind Phase III Study of Ibrutinib During and Following Autologous Stem Cell Transplantation Versus Placebo in Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma of the Activated B-cell Subtype
Primary Investigator: Karen Ballen
Clinical Research Coordinator: Kristen Johnson
Neuroblastoma (IRB-HSR #19031)
Treatment of Neuroblastoma and GD2-Positive Tumors with Activated T Cells Armed with OKT3 X Humanized 3F8 Bispecific Antibodies (GD2Bi): A Phase I/II Study
Primary Investigator: Daniel Lee
Clinical Research Coordinator: Candace Hudspeth
Type 1 Diabetes (IRB-HSR #18237)
Clinical Research Study Examining the Impact of Fitness and Mineralocorticoid Receptor Blockade on Vascular Dysfunction in Adults with Type 1 Diabetes
Primary Investigator: Eugene Barrett
Clinical Research Coordinator: Leona Hartline
Acute Myeloid Leukemia (IRB-HSR #19366)
A Randomized, Double-Blind Phase 3 Study of Vadastuximab Talirine (SGN-CD33A) Versus Placebo in Combination with Azacitidine or Decitabine in the Treatment of Older Patients with Newly Diagnosed Acute Myeloid Leukemia (NCT02785900)
Primary Investigator: Michael Keng
Clincal Research Coordinator: Amelia Hodson
Myelodysplastic Syndrome (IRB-HSR #19703)
A Phase 3 International, Randomized, Controlled Study of Rigosertib Versus Physician¿s Choice of Treatment in Patients with Myelodysplastic Syndrome After Failure of a Hypomethylating Agent (NCT02562443)
Primary Investigator: Michael Keng
Clincal Research Coordinator: Amelia Hodson
